当前位置:首页 - 行情中心 - 尔康制药(300267) - 财务分析 - 资产负债表

尔康制药

(300267)

  

流通市值:37.41亿  总市值:54.25亿
流通股本:14.22亿   总股本:20.63亿

资产负债表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
流动资产:
货币资金668,368,156.84638,895,895.28535,043,558.26744,349,595.87
应收票据及应收账款131,476,574.59132,007,528.12143,894,536.53146,992,409.94
其中:应收票据40,464,805.5724,571,252.4835,097,987.8637,838,273.19
应收账款91,011,769.02107,436,275.64108,796,548.67109,154,136.75
应收款项融资26,909,443.3440,518,259.1534,210,721.0230,806,644.06
预付款项13,128,590.39,167,340.175,190,944.368,090,607.37
其他应收款合计25,487,884.7410,886,556.6719,262,949.5418,172,661.15
存货648,344,562.54691,485,904.88701,294,925.68691,603,264.38
其他流动资产65,334,745.0969,286,444.91216,400,264.3990,879,770.27
流动资产平衡项目0000
流动资产合计1,679,049,957.441,692,247,929.111,725,441,099.781,731,013,553.04
非流动资产:
长期股权投资119,527,524.25119,657,377.27119,900,806.81120,229,041.21
其他权益工具投资50,000,00050,000,00050,000,00050,000,000
投资性房地产78,883,943.5679,685,313.3980,486,683.1881,288,053.01
固定资产2,518,734,356.882,552,118,924.012,576,142,356.892,577,832,463.04
在建工程236,790,125.51245,915,335.69221,257,207.56220,890,498.68
使用权资产136,505,911.58117,029,224.76117,661,914.12118,606,849.27
无形资产361,014,016.27366,611,169.51372,249,748.76378,033,817.06
商誉2,003,166.562,003,166.562,003,166.562,003,166.56
长期待摊费用10,900,394.2410,960,140.1113,618,997.7212,076,529.09
递延所得税资产151,790,359.25151,729,801.01152,050,505.62152,137,202.17
其他非流动资产48,893,224.3240,055,253.2731,044,465.534,957,684.61
非流动资产平衡项目0000
非流动资产合计3,715,043,022.423,735,765,705.583,736,415,852.723,748,055,304.7
资产平衡项目0000
资产总计5,394,092,979.865,428,013,634.695,461,856,952.55,479,068,857.74
流动负债:
短期借款399,393,472.23340,208,472.23351,026,250341,889,166.67
交易性金融负债822,000--538,400
应付票据及应付账款122,547,840.63146,139,329.3157,399,347.74122,299,149.22
应付账款122,547,840.63146,139,329.3157,399,347.74122,299,149.22
合同负债41,502,079.5238,952,466.0236,717,002.1547,013,865.09
应付职工薪酬9,363,5399,937,343.8810,560,669.5623,857,997.41
应交税费7,246,251.918,027,117.558,062,413.589,303,386.69
其他应付款合计26,546,086.9526,793,656.8429,497,677.0131,848,209.89
一年内到期的非流动负债920,021.891,872,660.572,181,653.172,156,803.17
其他流动负债18,600,848.613,900,297.0224,782,749.8324,394,033.64
流动负债平衡项目0000
流动负债合计626,942,140.73585,831,343.41620,227,763.04603,301,011.78
非流动负债:
租赁负债5,962,052.91385,365.17612,449.711,167,270.83
递延收益16,169,276.1317,408,748.2118,648,220.2918,385,950.19
递延所得税负债46,670,219.8946,568,652.7846,491,989.5746,200,440.26
非流动负债平衡项目0000
非流动负债合计68,801,548.9364,362,766.1665,752,659.5765,753,661.28
负债平衡项目0000
负债合计695,743,689.66650,194,109.57685,980,422.61669,054,673.06
所有者权益(或股东权益):
实收资本(或股本)2,062,604,8702,062,604,8702,062,604,8702,062,604,870
资本公积1,019,459,930.441,019,459,930.441,019,459,930.441,019,459,930.44
其他综合收益-8,886,059.6837,291,480.3942,142,013.2976,091,641.59
专项储备664,399.18659,970.26510,779.64426,836.46
盈余公积129,884,442.27129,884,442.27129,884,442.27129,884,442.27
未分配利润1,522,110,741.091,553,878,212.61,550,479,519.151,547,578,057.41
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计4,725,838,323.34,803,778,905.964,805,081,554.794,836,045,778.17
少数股东权益-27,489,033.1-25,959,380.84-29,205,024.9-26,031,593.49
股东权益平衡项目0000
股东权益合计4,698,349,290.24,777,819,525.124,775,876,529.894,810,014,184.68
负债和股东权益合计5,394,092,979.865,428,013,634.695,461,856,952.55,479,068,857.74
公告日期2024-10-252024-08-292024-04-272024-04-25
审计意见(境内)标准无保留意见
TOP↑